Are phospholipid-binding antibodies implicated in the pathogenesis of diabetic microangiopathy?

Medical Hypotheses

Volumn 63, Issue 2, 2004, Pages 235-238

  Giusti, Cristiano ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b I 00189 Rome ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; PHOSPHOLIPID ANTIBODY; PROTEIN C; THROMBOMODULIN;

ANTIBODY PRODUCTION; COMPLEMENT ACTIVATION; DIABETIC MICROANGIOPATHY; HEMOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 3242755116     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.02.019     Document Type: Article

References (21)

1. Albert D.M., Jakobiec F.A. Principles and practice of ophthalmology. 1994;Saunders, Philadelphia
2. Giusti C. Retinopathy in juvenile diabetes: a 10-year (1990-2000) review. Pediatr. Diabetes. 2:2001;83-93
3. Aiello L.P., Cahill M.T., Wong J.S. Systemic considerations in the management of diabetic retinopathy. Am. J. Ophthalmol. 132:2001;760-776
4. Aiello L.M. Perspectives on diabetic retinopathy. Am. J. Ophthalmol. 136:2003;122-135
5. Klein R., Klein B.E., Moss S.E., et al. Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. Ophthalmology. 110:2003;2118-2125
6. Giusti C., Schiaffini R., Brufani C., et al. Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients. Br. J. Ophthalmol. 84:2000;591-595
7. Jones D.B., Wallace R., Frier B.M. Vascular endothelial cell antibodies in diabetic patients. Association with diabetic retinopathy. Diabetes Care. 15:1992;552-555
8. Galtier-Dereure F., Biron C., Vies M., et al. Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies? Lupus. 7:1998;469-474
9. Giusti C., Schiaffini R., Bosco D., et al. Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy? Br. J. Ophthalmol. 84:2000;531-533
10. Levy D.M., Massicotte M.P., Harvey E., et al. Thromboembolism in paediatric lupus patients. Lupus. 12:2003;741-746
11. Neville C., Rauch J., Kassis J., et al. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb. Haemost. 90:2003;108-115
12. Sairam S., Baethge B.A., McNearney T. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies. Clin. Rheumatol. 22:2003;24-29
13. Huang Z., Jacewicz M., Pfeiffer R.F. Anticardiolipin antibody in vascular parkinsonism. Mov. Disord. 17:2002;992-997
14. Tanne D., Levine S.R., Brey R.L., et al. Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial. Neurology. 61:2003;1158-1159
15. Hartnett M.E., Laposata M., Van Cott E. Antiphospholipid antibody syndrome in a six-year-old female patient. Am. J. Ophthalmol. 135:2003;542-544
16. Ebeling F., Petaja J., Alanko S., et al. Infant stroke and beta-2-glycoprotein 1 antibodies: six cases. Eur. J. Pediatr. 162:2003;678-681
17. Crowther M.A., Ginsberg J.S., Julian J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N. Engl. J. Med. 349:2003;1133-1138
18. Derksen R.H., De Groot P.G., Kappelle L.J. Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome. Neurology. 61:2003;111-114
19. Ciarla M.V., Bocciarelli A., Di Gregorio S., et al. Autoantibodies and endothelial dysfunction in well-controlled, uncomplicated insulin-dependent diabetes mellitus patients. Atherosclerosis. 158:2001;241-246
20. Mohamed S.M., Abdou M.O., Assem H.M., et al. Anticardiolipin antibodies in children with insulin-dependent diabetes mellitus. Metabolism. 51:2002;1148-1152
21. Niskanen L., Lindi V., Erkkila A., et al. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects. Metabolism. 52:2003;213-217